AdaptHealth (AHCO)
(Delayed Data from NSDQ)
$9.69 USD
-0.07 (-0.72%)
Updated May 8, 2024 04:00 PM ET
After-Market: $9.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Price, Consensus and EPS Surprise
AHCO 9.69 -0.07(-0.72%)
Will AHCO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AHCO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AHCO
AdaptHealth Corp. (AHCO) Lags Q1 Earnings Estimates
Lantheus Holdings (LNTH) Q1 Earnings and Revenues Beat Estimates
AHCO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Philips (PHG) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
AHCO vs. BSX: Which Stock Is the Better Value Option?
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
Other News for AHCO
AdaptHealth Corp. to Participate in the BofA Securities 2024 Health Care Conference
AdaptHealth’s Strong Q1 Performance and Positive Future Outlook Warrant a Buy Rating
Underperform Rating Due to AdaptHealth’s Mixed Financial Outlook and Operational Hurdles
AdaptHealth Corp (AHCO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue and EBITDA ...
AHCO Stock Earnings: AdaptHealth Misses EPS, Beats Revenue for Q1 2024